首页> 外国专利> Stent-based delivery statins to prevent restenosis

Stent-based delivery statins to prevent restenosis

机译：基于支架的他汀类药物可预防再狭窄

页面导航

摘要
著录项
相似文献

摘要

Restenosis of arteries after angioplasty in inhibited by implanting in the treated artery a stent (100) having the struts (102) coated with a composition including a statin (106) having anti-restenotic activity. Such statins may also be incorporated in a collagen or polymer matrix (106) that forms a coating covering the struts (102) and interstices (104) of the stent (100).

机译：通过在治疗的动脉中植入支架（ 100 ）来抑制血管成形术后的动脉再狭窄，该支架的支撑杆（ 102 ）涂有包括他汀类药物（ 106 ）具有抗再狭窄活性。这些他汀类药物也可以掺入胶原蛋白或聚合物基质（ 106 ）中，以形成覆盖撑杆（ 102 ）和间隙（ 104 ）（ 100 ）。 展开▼

著录项

公开/公告号US2004148013A1

专利类型

公开/公告日2004-07-29

原文格式PDF

申请/专利权人 EPSTEIN STEPHEN E;FUCHS SHMUEL;STABILE EUGENIO;
展开▼

申请/专利号US20030476215

发明设计人 SHMUEL FUCHS;STEPHEN E EPSTEIN;EUGENIO STABILE;
展开▼

申请日2003-10-28

分类号A61F2/06;

国家 US

入库时间 2022-08-21 23:20:57

相似文献

专利

外文文献

中文文献

1. 用于预防支架内再狭窄的药物组合物 [P] . 中国专利： CN113412118A . 2021-09-17

2. 一种预防再狭窄的颈动脉用支架 [P] . 中国专利： CN213821902U . 2021-07-30

3. STENT-BASED DELIVERY OF STATINS TO PREVENT RESTENOSIS [P] . 欧洲知识产权局专利： EP1383447A4 . 2007-04-04

机译：基于事件的statin交付以防止再造血

4. STENT-BASED DELIVERY OF STATINS TO PREVENT RESTENOSIS [P] . 欧洲知识产权局专利： EP1383447A1 . 2004-01-28

机译：基于事件的statin交付以防止再造血

5. STENT-BASED DELIVERY OF STATINS TO PREVENT RESTENOSIS [P] . 世界知识产权组织专利： WO02087472A8 . 2003-02-27

机译：基于事件的statin交付以防止再造血

1. Clinical study about the effect of Simiao Yong'an Decoction on preventing in-stent restenosis and regulating inflammation and oxidative stress after lower extremity stent angioplasty stenting [J] . Jing Yang, Min-Hao Lu 海南医科大学学报（英文版） . 2019,第021期

2. Clinical study about the effect of Simiao Yong''''an Decoction on preventing in-stent restenosis and regulating inflammation and oxidative stress after lower extremity stent angioplasty stenting [J] . Jing Yang, Min-Hao Lu 海南医科大学学报(英文版) . 2019,第021期

3. Stent-Based Plasmid Gene Delivery into Porcine Coronary Artery [C] . L.H. Zhang, T. Luo, C. Zhang, World congress on medical physics and biomedical engineering;International congress of the IUPESM . 2011

4. Numerical simulations of stent-based local drug delivery: 2D geometric investigations and the evaluation of 3D stent designs on the basis of local delivery effectiveness. [D] . Bulman-Fleming, Neil. 2004

5. Stent-based delivery of adeno-associated viral vectors with sustained vascular transduction and iNOS-mediated inhibition of in-stent restenosis [O] . Ilia Fishbein, David T. Guerrero, Ivan S. Alferiev, -1

6. TAXUS III Trial: In-Stent Restenosis Treated With Stent-Based Delivery of Paclitaxel Incorporated in a Slow-Release Polymer Formulation [O] . Tanabe K. (Kengo), Degertekin M. (Muzaffer), Grube E. (Eberhard), 2003

1. Local Delivery of C-myc Antisense Oligodeoxynucleotide by Gelatin Coated Platinium-Iridium Stent to Prevent Restenosis in a Normal Rabbit Carotid Artery [J] . 张新霞 ,魏文斌 ,段雯 . 岭南心血管病杂志：英文版 . 2005,第1期

2. Exploring the Relationship between Statins and Alzheimer’s Disease: Can Statins Really Prevent Alzheimer’s Disease? [J] . Massud Atta . 阿尔茨海默氏病研究进展（英文） . 2015,第1期

3. Clinical Observation on Antiruisi Prescription (安替瑞丝方) in Preventing Restenosis after Coronary Artery Stenting [J] . 贾海忠 ,史载祥 ,柯元楠 . 中国中西医结合杂志：英文版 . 2004,第2期

4. 下肢动脉支架成形术后盐酸沙格雷脂联合阿司匹林预防再狭窄的临床观察 [C] . 杨国凯 ,杨镛 ,万嘉 . 第七届北京五洲心血管病研讨会 . 2013

5. 雷帕霉素支架预防再狭窄实验研究及支架内再狭窄相关因素临床分析 [A] . 刘学波 . 2002